EDAN Instruments, Inc. announced the official launch of the first-of-its-kind POC (Point-of-Care) fluorescence-based CO-OX blood gas and chemistry analysis system, i20, equipped with over 45 parameters, covering from blood gases, electrolyte, to CO-oximetry during the 74th American Association for Clinical Chemistry Annual Scientific Meeting and Clinical Laboratory Exposition (2022 AACC). EDAN held a series of live demonstrations of i20 in booth 1038 at McCormick Place Convention Center, Chicago, Jul. 26-28.

The new system is designed to relieve the burden in selected patient care settings like intensive care units, pulmonary units, emergency departments, operating rooms, neonatal intensive care, etc. The technology and its photoluminescent biosensor increase the accuracy and stability sharply while eliminating the cost of maintenance, space, and staff training. The blood gas test is considered the most important POC test by many emergency-care providers.

The newly added analytes (tHb, sO2, FO2Hb, FHHb, FCOHb, FMetHb) on i20, are tailored to the typical clinical applications of CO-oximetry, like poisoning or other clinical situations that alter Hb's ability to carry oxygen.